+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

SDS Poly Acrylamide Gel Electrophoresis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 212 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5916038
The global SDS Poly Acrylamide Gel Electrophoresis Market is experiencing significant growth, with revenues reaching approximately US$ 499 Million in 2024. Projections experts indicate that the market is poised to grow at a robust CAGR, aiming to achieve a valuation of around US$ 800 Million by the end of 2031.

Factors Fueling Market Growth

Rising Use of SDS-PAGE in Western Blotting and Advancements in Stain-Free Gels

The use of SDS-PAGE (Sodium Dodecyl Sulfate Poly Acrylamide Gel Electrophoresis) in Western blotting, a technique for identifying target proteins, has seen significant technological advancements in recent years. SDS-PAGE separates proteins based on their molecular weight and is recommended for Western blotting due to its ability to coat hydrophobic protein areas with a negative charge. This counteracts the protein's positive charge, enabling it to migrate towards the positive electrode. Advancements in stain-free gels for better visualization have further driven market growth, with stain-free gels offering improved sensitivity and dynamics for protein detection.

Minimizing Health Hazards in SDS-PAGE

Manufacturers are prioritizing the development of safe and reliable products, particularly concerning health hazards associated with SDS (Sodium Dodecyl Sulfate) exposure. Inhalation of SDS can cause health issues, especially in individuals with conditions like asthma. Ensuring product safety has led to lucrative opportunities in the market.

Challenges Impacting Market Growth

Lack of Innovation and Precise Alternatives

Despite its efficiency, electrophoresis techniques, including SDS-PAGE, require improvement in terms of run time, resolution, and automation. Alternative techniques such as flow cytometry and immunohistochemistry are being used to assess protein expression on a cell-by-cell basis. Additionally, the denaturation of proteins during SDS-PAGE is a challenge, as it restricts certain protein assessments. Alternative methods like blue-native PAGE are being explored for such cases, potentially affecting SDS-PAGE demand.

Post SDS-PAGE Complications and Side Effects

Complications, though relatively rare, can occur post SDS-PAGE procedures, such as pancreatitis, hemorrhage, infections, perforations, and strictures. These complications may impact patient outcomes and the market's growth trajectory.

Country-wise Insights

United States: Thriving Market

The United States is witnessing robust demand for SDS-PAGE due to substantial investments in research and development and expanding protein quantification research programs. Increased government funding for proteomics research initiatives and the presence of leading SDS-polyacrylamide gel electrophoresis manufacturers contribute to the country's thriving market.

Germany: Growing Clinical Research

Germany's market is expanding, driven by advanced medical knowledge and access to equipment. The country's focus on clinical research, along with its ability to attract outsourcing partnerships, sustains market growth.

China: Increasing R&D Investments

China has emerged as a prominent market with growing funding in research and development. Federal agencies and organizations in China have received substantial funding for research on vaccines, drugs, and other scientific endeavors. Research and development investments have contributed significantly to China's productivity growth.

Competitive Landscape Analysis

The SDS Poly Acrylamide Gel Electrophoresis market features several significant competitors, and leading companies are employing various strategic activities to strengthen their positions. Partnerships, joint ventures, product launches, and other techniques are being utilized by key players to remain competitive and stay attuned to market trends.

Key Companies' Profile

  • Bio-Rad Laboratories, Inc.
  • General Electric Company (GE Healthcare)
  • Merck KGaA (Sigma Aldrich)
  • Thermo Fisher Scientific Inc.
  • Analytik Jena Ag
  • Lonza Group Ltd.
  • Genscript Biotech Corporation
  • Abcam Plc
  • Takara Bio Inc.
  • Promega
  • Cleaver Scientific Ltd.

Key Segments Covered in SDS Poly Acrylamide Gel Electrophoresis Industry Research

Product:

  • Instruments
  • Reagents
  • Gels
  • Handcast Gels
  • Precast Gels

End User:

  • Clinical Research
  • Biotechnology and Pharmaceutical Industry
  • Government Agencies
  • Academic Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global SDS Poly Acrylamide Gel Electrophoresis Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global SDS Poly Acrylamide Gel Electrophoresis Market Outlook, 2018 - 2031
3.1. Global SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Instruments
3.1.1.2. Reagents
3.1.1.3. Gels
3.1.1.3.1. Handcast Gels
3.1.1.3.2. Precast Gels
3.2. Global SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Clinical Research
3.2.1.2. Biotechnology and Pharmaceutical Industry
3.2.1.3. Government Agencies
3.2.1.4. Academic Institutes
3.3. Global SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, 2018 - 2031
4.1. North America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Instruments
4.1.1.2. Reagents
4.1.1.3. Gels
4.1.1.3.1. Handcast Gels
4.1.1.3.2. Precast Gels
4.2. North America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Clinical Research
4.2.1.2. Biotechnology and Pharmaceutical Industry
4.2.1.3. Government Agencies
4.2.1.4. Academic Institutes
4.3. North America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
4.3.1.2. U.S. SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
4.3.1.3. Canada SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
4.3.1.4. Canada SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe SDS Poly Acrylamide Gel Electrophoresis Market Outlook, 2018 - 2031
5.1. Europe SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Instruments
5.1.1.2. Reagents
5.1.1.3. Gels
5.1.1.3.1. Handcast Gels
5.1.1.3.2. Precast Gels
5.2. Europe SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Clinical Research
5.2.1.2. Biotechnology and Pharmaceutical Industry
5.2.1.3. Government Agencies
5.2.1.4. Academic Institutes
5.3. Europe SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.2. Germany SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.3. U.K. SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.4. U.K. SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.5. France SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.6. France SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.7. Italy SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.8. Italy SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.9. Turkey SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.10. Turkey SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.11. Russia SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.12. Russia SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.13. Rest of Europe SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.14. Rest of Europe SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific SDS Poly Acrylamide Gel Electrophoresis Market Outlook, 2018 - 2031
6.1. Asia Pacific SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Instruments
6.1.1.2. Reagents
6.1.1.3. Gels
6.1.1.3.1. Handcast Gels
6.1.1.3.2. Precast Gels
6.2. Asia Pacific SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Clinical Research
6.2.1.2. Biotechnology and Pharmaceutical Industry
6.2.1.3. Government Agencies
6.2.1.4. Academic Institutes
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.2. China SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.3. Japan SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.4. Japan SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.5. South Korea SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.6. South Korea SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.7. India SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.8. India SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.9. Southeast Asia SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.10. Southeast Asia SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, 2018 - 2031
7.1. Latin America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Instruments
7.1.1.2. Reagents
7.1.1.3. Gels
7.1.1.3.1. Handcast Gels
7.1.1.3.2. Precast Gels
7.2. Latin America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.2.1.1. Clinical Research
7.2.1.2. Biotechnology and Pharmaceutical Industry
7.2.1.3. Government Agencies
7.2.1.4. Academic Institutes
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.2. Brazil SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.3. Mexico SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.4. Mexico SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.5. Argentina SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.6. Argentina SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.7. Rest of Latin America SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.8. Rest of Latin America SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa SDS Poly Acrylamide Gel Electrophoresis Market Outlook, 2018 - 2031
8.1. Middle East & Africa SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Instruments
8.1.1.2. Reagents
8.1.1.3. Gels
8.1.1.3.1. Handcast Gels
8.1.1.3.2. Precast Gels
8.2. Middle East & Africa SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Clinical Research
8.2.1.2. Biotechnology and Pharmaceutical Industry
8.2.1.3. Government Agencies
8.2.1.4. Academic Institutes
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa SDS Poly Acrylamide Gel Electrophoresis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.2. GCC SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.3. South Africa SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.4. South Africa SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.5. Egypt SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.6. Egypt SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.7. Nigeria SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.8. Nigeria SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa SDS Poly Acrylamide Gel Electrophoresis Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa SDS Poly Acrylamide Gel Electrophoresis Market by End User, Value (US$ Mn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Bio-Rad Laboratories, Inc.
9.4.1.1. Company Overview
9.4.1.2. Therapy Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. General Electric Company (GE Healthcare)
9.4.2.1. Company Overview
9.4.2.2. Therapy Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Merck KGaA (Sigma Aldrich)
9.4.3.1. Company Overview
9.4.3.2. Therapy Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Thermos Fisher Scientific Inc.
9.4.4.1. Company Overview
9.4.4.2. Therapy Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Analytik Jena Ag
9.4.5.1. Company Overview
9.4.5.2. Therapy Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Lonza Group Ltd.
9.4.6.1. Company Overview
9.4.6.2. Therapy Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Genscript Biotech Corporation
9.4.7.1. Company Overview
9.4.7.2. Therapy Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Abcam Plc
9.4.8.1. Company Overview
9.4.8.2. Therapy Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Takara Bio Inc.
9.4.9.1. Company Overview
9.4.9.2. Therapy Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Promega
9.4.10.1. Company Overview
9.4.10.2. Therapy Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Cleaver Scientific Ltd.
9.4.11.1. Company Overview
9.4.11.2. Therapy Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bio-Rad Laboratories, Inc.
  • General Electric Company (GE Healthcare)
  • Merck KGaA (Sigma Aldrich)
  • Thermos Fisher Scientific Inc.
  • Analytik Jena Ag
  • Lonza Group Ltd.
  • Genscript Biotech Corporation
  • Abcam Plc
  • Takara Bio Inc.
  • Amerigo Scientific
  • Promega
  • Cleaver Scientific Ltd.

Methodology

Loading
LOADING...